Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Water Resources Invesco ETF (PHO)

Water Resources Invesco ETF (PHO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The AI Pick-and-Shovel Trade Hiding in Plain Sight: Stocks & ETFs to Invest in Water

As Microsoft unveils a new community-friendly face on its data center land grab, our top technical strategist explains the ‘Mad Max’-style investing thesis bubbling up under the surface.

MSFT : 421.92 (+2.01%)
CGW : 67.22 (+0.13%)
AQWA : 20.38 (+0.05%)
FIW : 114.74 (+0.55%)
PHO : 73.45 (+0.25%)
UUUU : 22.34 (-3.29%)
GEV : 792.12 (-1.18%)
VLTO : 93.19 (+0.54%)
XYL : 131.33 (-6.32%)
LEU : 267.25 (-3.25%)
ECL : 296.20 (+2.79%)
The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison

OSLO, Norway , Dec. 8, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of a health economics abstract from the BRAVO study at the Society...

PHO : 73.45 (+0.25%)
Photocure ASA: Results for the third quarter of 2025

OSLO, Norway , Oct. 29, 2025 /PRNewswire/ --  Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 134.1 million in the third quarter of 2025 (Q3 2024:...

PHO : 73.45 (+0.25%)
Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy

OSLO, Norway , Oct. 15, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO ), the Bladder Cancer Company, announces that it has entered into a partnership with Intelligent Scopes Corporation...

PHO : 73.45 (+0.25%)
Photocure ASA: Results for the second quarter of 2025

OSLO, Norway , July 30, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ®  revenues of NOK 135.6 million ...

PHO : 73.45 (+0.25%)
This Simple Industrials ETF Could Turn $1,000 a Month Into $612,000

The Invesco Water Resources ETF could be a great evergreen investment.

PHO : 73.45 (+0.25%)
IVZ : 27.42 (+1.97%)
Veralto Stock: Analyst Estimates & Ratings

Although Veralto has outperformed relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

$SPX : 6,975.66 (+0.16%)
PHO : 73.45 (+0.25%)
VLTO : 93.19 (+0.54%)
Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress

/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has today unveiled the...

PHO : 73.45 (+0.25%)
Buy This ETF to Profit From the Semiconductor Industry's Water Crisis

The rise of AI is fueling insatiable demand for semiconductors - and worsening a water shortage that no one on Wall Street seems to be paying attention to. Here are 3 ETFs for investors looking to profit...

MSFT : 421.92 (+2.01%)
NVDA : 189.82 (-0.12%)
CGW : 67.22 (+0.13%)
TSLA : 422.29 (+1.19%)
FIW : 114.74 (+0.55%)
INTC : 48.12 (-4.22%)
PHO : 73.45 (+0.25%)
MU : 370.34 (-3.43%)
TSM : 361.09 (+1.60%)
Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint

/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today...

PHO : 73.45 (+0.25%)

Barchart Exclusives

1 High-Yield Dividend Stock That’s Up 148% Over the Past Year
Millicon International Cellular (TIGO) is up 148% over the past 52 weeks. TIGO maintains a 100% “Buy” technical opinion from Barchart. TIGO's fundamentals are robust with strong revenue and earnings growth estimates. Analyst sentiment is overwhelmingly positive, with multiple “Strong Buy” ratings. Today’s Featured Stock Valued at $11.52 billion, Millicon... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar